TAMPA, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC, founded in 1994, is a major nonprofit in the Diseases & Disorders sector that reported $173.2M in total revenue in fiscal year 2024. Revenue grew 19% year-over-year, indicating healthy expansion. Expenses of $385.2M exceeded revenue, resulting in a 122% operating deficit.
TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC (INSTITUTE), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL (HOSPITAL), AND H. LEE MOFFITT CANCER FOUNDATION BY EMPLOYING PHYSICIANS WHO STAFF THE HOSPITAL, BY MANAGING THEIR PRACTICE AND BY EMPLOYING THE CLINICAL SCIENTISTS WHO PROVIDE CLINICAL RESEARCH SERVICES.
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE...
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER HEALTH CARE SYSTEM. THE PROVISION OF PRACTICE MANAGEMENT SERVICES TO ITS EMPLOYED PHYSICIANS AND CLINICAL SCIENTISTS ENHANCES THE EFFICIENCY OF HEALTHCARE AND RESEARCH SERVICES PROVIDED BY THESE EMPLOYEES. THIS BENEFITS ALL ENTITIES IN THE CANCER CENTER HEALTH CARE SYSTEM AND PROMOTES AND SUPPORTS THE RESEARCH AND ACADEMIC MISSIONS OF THE CANCER CENTER HEALTH CARE SYSTEM.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $173,244,422 | $145,660,440 | +0.2% |
| Expenses | $385,166,297 | $341,004,009 | +0.1% |
| Net Income | $-211,921,875 | $-195,343,569 | +0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MICHAEL A VOGELBAUM | PRG LDR NEURO ONCOLOGY | 50.00 |
Highest
|
$1,199,083 | $81,546 | $1,280,629 |
| JULIO M POW-SANG MD | DEPT CHAIR GU | 50.00 |
Highest
|
$1,037,540 | $221,041 | $1,258,581 |
| G DOUGLAS LETSON | FRM PRES, EVP-PIC TO 6/2024 | 19.00 |
|
$597,591 | $162,524 | $1,186,546 |
| RICARDO J GONZALEZ | DEPT CHAIR SARCOMA | 50.00 |
Highest
|
$1,024,757 | $146,170 | $1,170,927 |
| LARY ROBINSON | SR MBR THORCARDIO | 50.00 |
Highest
|
$1,021,735 | $133,786 | $1,155,521 |
| ERIC TOLOZA | VICE CHAIR THORACIC | 50.00 |
Highest
|
$1,035,085 | $95,663 | $1,130,748 |
| L DAVID DE LA PARTE | FRM EVP-GEN CO; ASST SEC TO 6/2024 | 5.00 |
|
$0 | $242,023 | $1,042,186 |
| ROBERT A GATENBY | DEPT CHAIR DIAGNOSTIC IMAGING | 55.00 |
Key Emp
|
$897,178 | $151,113 | $1,048,291 |
| JOANNA WEISS | EVP CFO & ASST TREASURER | 5.00 |
Officer
|
$0 | $139,001 | $972,388 |
| HUGO FERNANDEZ MD | DIR, DEPT CHAIR MAL HEM MHS | 56.00 |
Key Emp
|
$870,600 | $120,269 | $990,869 |
| PETER JOHSTONE | DEPT CHAIR RADIATION ONCOLOGY | 55.00 |
Key Emp
|
$848,315 | $116,517 | $964,832 |
| KOSJ YAMOAH | DEPT CHAIR RADIATION ONCOLOGY | 55.00 |
Key Emp
|
$886,273 | $80,702 | $966,975 |
| JOHN A ARRINGTON | VICE CHAIR DIAGNOSTIC IMAGING | 55.00 |
Key Emp
|
$773,342 | $160,713 | $934,055 |
| DONALD L KLIPPENSTEIN | VICE CHAIR DIAGNOSTIC IMAGING | 55.00 |
Key Emp
|
$733,413 | $130,764 | $864,177 |
| BELA KIS | VICE CHAIR DIA IMAGING AS OF 12/2024 | 55.00 |
Key Emp
|
$702,748 | $96,459 | $799,207 |
| DAVID N THRUSH | FRM DEPT CHAIR ANESTH TO 6/2023 | 50.00 |
|
$593,847 | $105,798 | $699,645 |
| SEPHALIE PATEL | DEPT CHAIR ANESTHESIOLOGY | 55.00 |
Key Emp
|
$639,002 | $58,109 | $697,111 |
| NIKHIL KHUSHALANI | DIR, ACD CLIN RES PART | 56.00 |
Key Emp
|
$586,026 | $89,010 | $675,036 |
| SUSAN VADAPARAMPIL | DIRECTOR NV | 1.00 |
Key Emp
|
$0 | $103,021 | $659,315 |
| CHARLES FLETCHER | EVP-GEN COUN & ASST SEC AS OF 7/2024 | 5.00 |
Officer
|
$0 | $117,472 | $661,814 |
| KAREN LU | PRES, EVP-PIC | 12.00 |
Officer
|
$0 | $16,406 | $634,219 |
| KAREN WARTENBERG | VP MOFFITT MEDICAL GROUP | 30.00 |
Officer
|
$0 | $118,439 | $615,822 |
| JONATHAN COHEN | VICE CHAIR ANESTHESIOLOGY | 55.00 |
Key Emp
|
$535,751 | $89,638 | $625,389 |
| EVAN ZASLOW | VP PAYER STRATEGIES | 19.00 |
Officer
|
$0 | $104,950 | $554,808 |
| NASRIN ALDAWOODI | VICE CHAIR ANESTHESIOLOGY TO 11/2024 | 55.00 |
Key Emp
|
$477,416 | $60,142 | $537,558 |
| MELISSA SMITH | VP FINANCE AS OF 8/2024 | 12.00 |
Officer
|
$108,421 | $52,706 | $296,401 |
| YVETTE M LYONS TREMONTI | FRM EVP-CFAO & ASST TREAS TO 5/2024 | 0.00 |
|
$0 | $65,937 | $596,052 |
| HENRY REYES | FRM VP-PARTNER DEV TO 4/2024 | 0.00 |
|
$0 | $25,185 | $130,852 |
| VICTOR YOUNG | DIRECTOR, CHAIR AS OF 10/2024 | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| FRANK CAPITANO | DIRECTOR, IMMED PAST CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| THE HON H LEE MOFFITT ESQ | DIRECTOR, SECRETARY/TREAS | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| MICHAEL BICE | DIRECTOR AS OF 3/2025 | 1.00 |
Director
|
$0 | $0 | $0 |
| JOEDRECKA BROWN SPEIGHTS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KATHERINE CHUNG-BRIDGES | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| REGINALD GOINS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ALLAN S MARTIN | DIRECTOR AS OF 10/2024 | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL O'MALLEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT J PEREZ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THE HON MARK A PIZZO ESQ | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARK WATSON | DIRECTOR TO 3/2025 | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $173,244,422 | $385,166,297 | $19,656,405 | $-211,921,875 |
| 2024 | No data | No data | No data | No data |
| 2023 | $134,329,298 | $296,514,684 | $15,261,265 | $-162,185,386 |
| 2022 | $123,544,468 | $252,506,573 | $11,794,402 | $-128,962,105 |
| 2021 | $113,723,496 | $238,724,192 | $12,286,490 | $-125,000,696 |
| 2020 | $105,957,712 | $222,827,092 | $12,167,150 | $-116,869,380 |
| 2019 | $97,674,225 | $197,257,659 | $10,571,913 | $-99,583,434 |
| 2018 | $95,552,604 | $170,241,340 | $9,167,760 | $-74,688,736 |
Compare H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC with other nonprofits in Florida and across the country.